The FDA and scientific priorities.
Science
; 377(6609): 905, 2022 08 26.
Article
in English
| MEDLINE | ID: covidwho-2019700
ABSTRACT
Earlier this year, when I was confirmed as the new commissioner of the US Food and Drug Administration (FDA), the world faced ongoing public health issues related to the pandemic and war in Ukraine, among other challenges. Most notably, the US is experiencing a flattening or decline in life expectancy compared with other high-income countries. As part of a wider effort to reverse this decline, relationships between FDA and the biomedical ecosystem should be reimagined to facilitate more effective translation of science into successful health interventions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Public Health
/
Life Expectancy
/
Ecosystem
/
Armed Conflicts
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Observational study
Country/Region as subject:
North America
/
Europa
Language:
English
Journal:
Science
Year:
2022
Document Type:
Article
Affiliation country:
Science.ade5003
Similar
MEDLINE
...
LILACS
LIS